Key Points
- CEO Sean Keohane sold 91,923 Cabot shares at an average price of $86.41, worth approximately $7.94 million, reducing his direct stake by 18.53% to 404,134 shares.
- Cabot exceeded quarterly expectations with EPS of $1.67 versus the $1.66 consensus and revenue of $982 million, up 6.4% year over year. Management guided to fiscal 2026 EPS of $6.15–$6.45.
- The company declared a quarterly dividend of $0.4725 per share, equivalent to an annualized $1.89 payout and a 2.2% yield. Analysts maintain a consensus “Hold” rating with an $89 average price target.
Cabot Corporation (NYSE:CBT - Get Free Report) CEO Sean Keohane sold 91,923 shares of the company's stock in a transaction on Friday, August 7th. The shares were sold at an average price of $86.41, for a total value of $7,943,066.43. Following the completion of the transaction, the chief executive officer directly owned 404,134 shares in the company, valued at $34,921,218.94. This represents a 18.53% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.
Cabot Price Performance
Shares of NYSE:CBT opened at $87.03 on Wednesday. The company has a market capitalization of $4.49 billion, a PE ratio of 24.52, a price-to-earnings-growth ratio of 11.28 and a beta of 0.84. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.97 and a current ratio of 1.47. The stock has a fifty day moving average of $87.90 and a 200-day moving average of $80.16. Cabot Corporation has a one year low of $58.33 and a one year high of $94.53.
Cabot (NYSE:CBT - Get Free Report) last announced its earnings results on Monday, August 3rd. The specialty chemicals company reported $1.67 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.66 by $0.01. Cabot had a return on equity of 20.29% and a net margin of 5.23%.The company had revenue of $982.00 million for the quarter, compared to analyst estimates of $943.16 million. During the same period in the previous year, the firm earned $1.90 earnings per share. Cabot's revenue for the quarter was up 6.4% compared to the same quarter last year. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. As a group, equities analysts anticipate that Cabot Corporation will post 6.33 EPS for the current fiscal year.
Cabot Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 11th. Shareholders of record on Friday, August 28th will be issued a dividend of $0.4725 per share. This represents a $1.89 annualized dividend and a yield of 2.2%. The ex-dividend date is Friday, August 28th. Cabot's payout ratio is presently 53.24%.
Analyst Ratings Changes
Several research analysts have commented on CBT shares. Wall Street Zen upgraded shares of Cabot from a "hold" rating to a "buy" rating in a report on Sunday. Mizuho boosted their price target on shares of Cabot from $80.00 to $90.00 and gave the company a "neutral" rating in a report on Thursday, June 25th. Truist Financial set a $100.00 price objective on shares of Cabot in a research note on Wednesday, August 5th. JPMorgan Chase & Co. lifted their price objective on shares of Cabot from $70.00 to $78.00 and gave the stock an "underweight" rating in a research report on Friday, August 7th. Finally, Weiss Ratings reissued a "hold (c)" rating on shares of Cabot in a research note on Tuesday, May 26th. Two analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company currently has an average rating of "Hold" and a consensus target price of $89.00.
View Our Latest Stock Report on Cabot
Hedge Funds Weigh In On Cabot
Several institutional investors and hedge funds have recently bought and sold shares of the business. NewEdge Advisors LLC lifted its position in shares of Cabot by 2,559.5% in the first quarter. NewEdge Advisors LLC now owns 984 shares of the specialty chemicals company's stock worth $82,000 after purchasing an additional 947 shares in the last quarter. Goldman Sachs Group Inc. grew its position in Cabot by 32.5% during the first quarter. Goldman Sachs Group Inc. now owns 442,646 shares of the specialty chemicals company's stock valued at $36,802,000 after purchasing an additional 108,645 shares in the last quarter. Empowered Funds LLC increased its stake in Cabot by 102.6% in the 1st quarter. Empowered Funds LLC now owns 28,162 shares of the specialty chemicals company's stock valued at $2,341,000 after buying an additional 14,260 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in Cabot by 3.4% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 122,022 shares of the specialty chemicals company's stock valued at $10,145,000 after buying an additional 4,048 shares during the period. Finally, Geneos Wealth Management Inc. lifted its position in Cabot by 409.0% in the 1st quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company's stock worth $38,000 after buying an additional 364 shares in the last quarter. Hedge funds and other institutional investors own 93.18% of the company's stock.
About Cabot
(
Get Free Report)
Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.
The company operates two primary segments: Reinforcement Materials and Performance Materials.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
